Opportunity Radar

← Back to search

Grant forecast

Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases (R01 Clinical Trials Required)

View on Grants.gov ↗ Sign in to save

Type
Grant forecast
Notice type
G
Agency
Food and Drug Administration
Sub-agency
HHS-FDA
Solicitation #
FOR-FD-25-020
Posted
Jul 11, 2025
CFDA / Assistance listing
93.103
Contact
Kimberly Pendleton · Kimberly.Pendleton@fda.hhs.gov · 240-402-7610
Source
Grants.gov

Description

The purpose of this opportunity is to fund clinical trials of products evaluating efficacy and/or safety in support of a new indication or change in labeling to address unmet needs in rare diseases or conditions. Additionally, through the funding of collaborative, efficient, and/or innovative clinical trials, FDA expects to increase the number of approved treatments for rare diseases and exert a broad and positive impact on rare disease drug development.

Similar open opportunities